9,200 CME Group Inc. $CME Shares Acquired by Danske Bank A S

Danske Bank A S boosted its position in CME Group Inc. (NASDAQ:CME – Free Report) by 4.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 237,356 shares of the financial services provider’s stock after buying an additional 9,200 shares during the period. Danske Bank A S’s holdings in CME Group were worth $62,183,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the company. BlackRock Inc. acquired a new stake in CME Group during the 2nd quarter worth about $6,749,965,000. Bank of America Corp DE raised its position in shares of CME Group by 39.1% in the 1st quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock worth $1,187,290,000 after acquiring an additional 1,130,587 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of CME Group in the 2nd quarter worth about $867,313,000. Alphabet Inc. bought a new position in shares of CME Group in the 2nd quarter worth about $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of CME Group in the 2nd quarter valued at about $629,771,000. Institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on CME shares. TD Cowen boosted their price objective on CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a research note on Monday, October 5th. Wall Street Zen raised CME Group from a “sell” rating to a “hold” rating in a research note on Saturday, October 31st. CLSA set a $367.00 target price on CME Group in a research note on Thursday, October 22nd. Piper Sandler reiterated an “overweight” rating and issued a $330.00 target price (up from $295.00) on shares of CME Group in a report on Thursday, October 22nd. Finally, JPMorgan Chase & Co. raised CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 price target on the stock in a research note on Thursday, October 22nd. Ten equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus target price of $314.44.

Get Our Latest Stock Report on CME

CME Group Price Performance

CME Group stock opened at $317.97 on Monday. The company has a market capitalization of $113.81 billion, a PE ratio of 26.08, a PEG ratio of 3.88 and a beta of 0.15. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The firm’s fifty day moving average is $286.01 and its 200 day moving average is $281.54. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. The business had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.71 billion. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The business’s quarterly revenue was up 10.6% on a year-over-year basis. During the same period last year, the company posted $2.68 earnings per share. As a group, sell-side analysts predict that CME Group Inc. will post 12.35 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be issued a dividend of $1.30 per share. The ex-dividend date is Friday, December 11th. This represents a $5.20 annualized dividend and a dividend yield of 1.6%. CME Group’s dividend payout ratio is currently 42.66%.

Insider Activity

In other news, Director Howard Siegel sold 2,000 shares of the stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $303.00, for a total transaction of $606,000.00. Following the transaction, the director owned 19,873 shares of the company’s stock, valued at $6,021,519. This represents a 9.14% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Sunil Cutinho sold 5,000 shares of the stock in a transaction dated Tuesday, October 27th. The stock was sold at an average price of $298.70, for a total transaction of $1,493,500.00. Following the transaction, the insider directly owned 20,037 shares in the company, valued at $5,985,051.90. This trade represents a 19.97% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 33,511 shares of company stock valued at $9,714,580. Corporate insiders own 0.30% of the company’s stock.

CME Group Company Profile

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.